- Presentations
- 2
- Markets
- 1
Enspryng is a brand of Satralizumab marketed by Genentech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Satralizumab
- Brand owner
- Genentech
- Registered in
- United States
- Strengths and forms
- 120 mg/1 mL injection, 180 mg/1.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Enspryng 120 mg/1 mL injectionSubcutaneous Cold chain | Genentech | US FDA | Available on request |
| Enspryng 180 mg/1.5 mL injectionSubcutaneous Cold chain | Genentech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Enspryng
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.